Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells.
Liu, Chun-Yu
Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells. [electronic resource] - Journal of molecular medicine (Berlin, Germany) Sep 2017 - 965-975 p. digital
Publication Type: Journal Article
1432-1440
10.1007/s00109-017-1549-x doi
Animals
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Cell Line, Tumor
Cell Proliferation--drug effects
Disease Models, Animal
Docetaxel
Drug Synergism
Female
Gene Expression Regulation, Neoplastic
Humans
Mice
Phenyl Ethers--pharmacology
Phenylurea Compounds--pharmacology
Prognosis
Protein Tyrosine Phosphatase, Non-Receptor Type 6--genetics
STAT3 Transcription Factor--metabolism
Signal Transduction--drug effects
Taxoids--pharmacology
Transcription, Genetic
Triple Negative Breast Neoplasms--genetics
Xenograft Model Antitumor Assays
Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells. [electronic resource] - Journal of molecular medicine (Berlin, Germany) Sep 2017 - 965-975 p. digital
Publication Type: Journal Article
1432-1440
10.1007/s00109-017-1549-x doi
Animals
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Cell Line, Tumor
Cell Proliferation--drug effects
Disease Models, Animal
Docetaxel
Drug Synergism
Female
Gene Expression Regulation, Neoplastic
Humans
Mice
Phenyl Ethers--pharmacology
Phenylurea Compounds--pharmacology
Prognosis
Protein Tyrosine Phosphatase, Non-Receptor Type 6--genetics
STAT3 Transcription Factor--metabolism
Signal Transduction--drug effects
Taxoids--pharmacology
Transcription, Genetic
Triple Negative Breast Neoplasms--genetics
Xenograft Model Antitumor Assays